Tumor-associated macrophages (TAMs) with M2 phenotype provide an immunosuppressive microenvironment for tumor growth. In contrast, A great deal of evidence indicates that macrophages in obese patients' adipose tissue undergo a phenotypic change from M2 to Ml polarization accelerating adipose tissue inflammation. Interestingly, obesity is considered a major risk factor for breast cancer.
Two distinct states of polarized activation for macrophages are known: the classically activated (MI) macrophage and the alternatively activated (M2) macrophage subsets (1) . MI macrophages can produce high levels of inducible nitric oxide synthase (iNOS; NOS2) to promote arginine metabolism into nitric oxide and citrulline (2) . M2 macrophages always express scavenger receptors, mannose receptors and IL-I 0, being mainly involved in tissue remodeling, immune modulation and tumor progression (3) . ' In tumors, the infiltrated macrophages are of the M2 phenotype, providing an immunosuppressive microenvironment facilitating tumor growth (4) . In contrast, a great deal of evidence indicates that macrophages in the adipose tissue of obese patients exhibit a phenotypic change from M2 to MI polarization, thereby accelerating adipose tissue inflammation (5) . In breast cancer the majority of tumor-associated macrophages (TAMs) exhibits alternatively activated M2 properties, produces abundant anti-inflammatory factors and facilitates tumor development (4, 6) . Though obese patients' adipose tissue shows an MI polarized population of macrophages, obesity is considered a major risk factor for breast cancer mainly in postmenopausal women (7) . However, to the best of our knowledge, no studies focusing on possible differences between macrophage activation in obese or non-obese women with breast cancer are available. Herein, we describe a case-control study between normal-weight and obese women with breast cancer. Activation states of 1\1. RENNE ET AL. macrophages and patterns ofinflammation associated to breast invasive ductal carcinoma were analyzed by immunohistochemistry. Body mass index (BMI) was calculated as weight divided by the square of height. Patients were divided into two groups based on the National Institute of Health (NIH) classification for obesity: normal weight (BMI: 18.5 to 25.0) and obese (BMI: 30.0 to 39.0) (8) . Control and case groups were matched for age and histopathological grade (Table I) . Patients with other concomitant diseases, such as diabetes and immunologic illness, were excluded from the study.
For our study archival formalin-fixed and paraffinembedded tissues were used. Histopathological (surgical resection) specimens diagnosed at the Department of Pathology of the School of Medicine ofthe University ofCatanzaro during the period 2006-2013 were evaluated. Seriated deparaffinated sections (4-flm thick) were used for staining procedures, haematoxylin and eosin and immunohistochemistry. All procedures were carried out at room temperature. All cases were then tested for iNOS (1: 100 dilution; Sigma) and CD68 (1: 1500 dilution; Dako) by means ofan automated immunostainer (Bond TM Max). The extent of infiltrating iNOS+ cells with a monocyte/ macrophage morphology, classically activated M 1 macrophage, in tumor stroma and border zone (large two 40x field) was evaluated (9) counting cells using image J (l 0) on five photos at x400 magnification. The two groups of tumors of obese and non-obese women were compared for number of iNOS+ cells via a Student's z-test. The tests were considered significant when P value was ::;0.05. The study was approved by the local ethics committee and informed consent was obtained. The main results for each group are summarized in Table 1 .
The Student's r-test results allow us to reject the null hypothesis in our series (P=0.021; for 54 degrees of freedom) concerning the two groups of tumors in obese and non-obese women. Qualitative analysis of neoplasia showed a very rich infiltrate of TAMs (CD68+) mainly in grade III for both groups (Fig. lA) . In the grade III tumor group, cases (three obese and three non-obese patients) with a dense inflammatory infiltrate at the periphery of neoplasia were observed (Fig.IB) . In such cases the count of iNOS+ macrophage showed no significant difference between two groups (Table II ) (P = 0.063; for 4 degrees of freedom).
In some other cases, the presence in the obese women tissue ofMl iNOS+ macrophages was linked with an infiltration in the fat of the tumoral cells, but without a relevant associated inflammatory infiltrate (Fig. 1C, lD) . In obese women a massive tumoral infiltrate of Ml cells may be present ( Fig. 2A, 2B) , conversely a scattered perilobular inflammation without tumoral macrophagic infiltrate can also be observed ( Fig. 2 C and D) .
Our results indicate that there is a significant difference of infiltration of M 1 activated macrophages between obese and non-obese women. However, such a difference must be determined with caution since it may be the result of the surrounding inflammation in the adipose tissue of obese women. When a strong peripheral infiltrate is present in the nearer border of neoplasia, the obese and non-obese population have no significant probability to assume the null hypothesis (Table II) . In this case, the strong inflammatory response might be promoted by the antigenicity of the scarcely differentiated neoplasia or other host linked factors. Finally, infiltration of fat is generally rarely followed by inflammation in obese patients; in such cases it is likely that factors from cancerous cells might be able to abolish the proinflammatory effect of M 1 macrophages resident in fat.
In conclusion, our study demonstrates that classically activated macrophages in obese patients outnumber classically activated macrophages in the breast of non-obese patients with infiltrating ductal carcinoma; however, cancer cell-linked factors may strongly antagonize M1 macrophages' positive effects by both stimulating their switching to M2 TAMs and inhibiting their effects.
It remains to be clarified why, in certain circumstances, a very rich peripheral inflammation with several classically activated cells is shown by tumors. However, recent articles have demonstrated that the adipose tissue ofobese patients is characterized by adipocyte hypertrophy, followed by increased angiogenesis, immune cell infiltration, extracellular matrix overproduction, and thus, increased production of proinflammatory adipocytokines during the progression of chronic inflammation (11, 12) . Such activity at the border of invasion of the tumor may prepare the surrounding tissue to infiltration.
